Author Archives: Sally Grosvenor

Novozymes Biopharma

          With over 45 years’ experience in microbial protein expression, we deliver animal-free, recombinant biological products and technologies to forward-thinking medical device, drug formulation, and drug delivery manufacturers. Working closely together with our customers, we can provide customized biological solutions to make their products safer and more effective while getting them to market faster and hassle free.   Recombinant Human Albumin (rHA)   A range of rHAs (Recombumin®, albucult®, CellPrimeâ„¢ rAlbumin AF-S) developed for industrial cell…

Supplements for Enhanced Cell Productivity

Figure 1. With over 60 years experience in microbial protein expression, Novozymes offers a range of animal-free recombinant supplements — designed and manufactured exclusively for industrial cell culture — that allow developers to “rethink” their media strategy. These products provide proven performance benefits in a defined and regulatory-compliant manner, ensuring optimal media development for enhanced cell productivity. Recombinant Human Albumin (rHA) Novozymes has developed a range of rHas (Recombumin®, albucult™, and CellPrime™ ralbumin AF-S) suitable for industrial cell culture and…